{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:04:46Z","timestamp":1792436686548,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009091","name":"Fundaci\u00f3 Catalana de Trasplantament","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clnu.2025.02.016","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T11:09:55Z","timestamp":1739790595000},"page":"157-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The effects of nutritional supplementation for children and adolescents with sickle cell disease: A systematic review and meta-analyses"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1733-1199","authenticated-orcid":false,"given":"Bruna C.","family":"Orsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5569-6588","authenticated-orcid":false,"given":"Daniela","family":"Gorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3570-6509","authenticated-orcid":false,"given":"Naila E.","family":"Krul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Wiens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-658X","authenticated-orcid":false,"given":"Miguel","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-8608","authenticated-orcid":false,"given":"Fernanda S.","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-4363","authenticated-orcid":false,"given":"Roberto","family":"Pontarolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2025.02.016_bib1","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1080\/10408398.2017.1319794","article-title":"The role of nutrition in the pathophysiology and management of sickle cell disease among children: a review of literature","volume":"58","author":"Ohemeng","year":"2018","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.clnu.2025.02.016_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-0042-1749612","article-title":"Zinc, magnesium, and copper levels in patients with sickle cell disease: a systematic review and meta-analysis","volume":"12","author":"Elkhidir","year":"2022","journal-title":"Avicenna J Med"},{"key":"10.1016\/j.clnu.2025.02.016_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30294","article-title":"Efficacy and safety of pharmacological interventions for managing sickle cell disease complications in children and adolescents: systematic review with network meta-analysis","volume":"70","author":"Tonin","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clnu.2025.02.016_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.clnu.2025.02.016_bib5","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S2352-3026(22)00004-7","article-title":"Estimating the risk of child mortality attributable to sickle cell anaemia in Sub-Saharan Africa: a retrospective, multicentre, case-control study","volume":"9","author":"Ranque","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.clnu.2025.02.016_bib6","article-title":"Recent advances in the treatment of sickle cell disease","volume":"11","author":"Salinas","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.clnu.2025.02.016_bib7","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3324\/haematol.2018.207357","article-title":"Emerging disease-modifying therapies for sickle cell disease","volume":"104","author":"Carden","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.clnu.2025.02.016_bib8","first-page":"1065","article-title":"Nutritional risk screening and assessment","volume":"8","author":"Reber","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clnu.2025.02.016_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/NDS.S168257","article-title":"Nutrition in sickle cell disease: recent insights","volume":"11","author":"Umeakunne","year":"2019","journal-title":"Nutr Diet Suppl"},{"key":"10.1016\/j.clnu.2025.02.016_bib10","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3906\/sag-1812-92","article-title":"Alterations in serum levels of copper, zinc, and selenium among children with sickle cell anemia","volume":"49","author":"Hasanato","year":"2019","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.clnu.2025.02.016_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-023-15343-1","article-title":"Knowledge and nutrition-related practices among caregivers of adolescents with sickle cell disease in the Greater Accra region of Ghana","volume":"23","author":"Ohemeng","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clnu.2025.02.016_bib12","article-title":"Vitamin D supplementation for sickle cell disease","author":"Soe","year":"2017","journal-title":"Cochrane Db Syst Rev"},{"key":"10.1016\/j.clnu.2025.02.016_bib13","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.38014","article-title":"Emerging therapies for the management of pain and vaso-occlusive crises in patients with sickle cell disease: a systematic review of randomized controlled trials","author":"Lowe","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.clnu.2025.02.016_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1167","article-title":"Effects of l-arginine supplementation in patients with sickle cell disease: a systematic review and meta-analysis of clinical trials","volume":"6","author":"Sadeghi","year":"2023","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.clnu.2025.02.016_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cca.2020.07.020","article-title":"Antioxidant nutrients and hemolysis in sickle cell disease","volume":"510","author":"Delesderrier","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clnu.2025.02.016_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/pbc.24163","article-title":"Micronutrients and sickle cell disease, effects on growth, infection and vaso-occlusive crisis: a systematic review","volume":"59","author":"Dekker","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clnu.2025.02.016_bib17","article-title":"Magnesium for treating sickle cell disease","author":"Than","year":"2019","journal-title":"Cochrane Db Syst Rev"},{"key":"10.1016\/j.clnu.2025.02.016_bib18","article-title":"Zinc supplements for treating thalassaemia and sickle cell disease","volume":"6","author":"Swe","year":"2013","journal-title":"Cochrane Db Syst Rev"},{"key":"10.1016\/j.clnu.2025.02.016_bib19","article-title":"Antioxidant supplementation for sickle cell disease","volume":"5","author":"Bolarinwa","year":"2024","journal-title":"Cochrane Db Syst Rev"},{"key":"10.1016\/j.clnu.2025.02.016_bib20","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.0","author":"Higgins","year":"2020"},{"key":"10.1016\/j.clnu.2025.02.016_bib21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network metaanalyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnu.2025.02.016_bib22","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"10.1016\/j.clnu.2025.02.016_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.clnu.2025.02.016_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jval.2011.01.011","article-title":"Conducting indirect treatment- comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2","volume":"14","author":"Hoaglin","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.clnu.2025.02.016_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jval.2011.04.002","article-title":"Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1","volume":"14","author":"Jansen","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.clnu.2025.02.016_bib26","series-title":"NMAstudio: a fully interactive web-application for producing and visualising network meta-analyses","author":"Tianqi","year":"2023"},{"key":"10.1016\/j.clnu.2025.02.016_bib27","unstructured":"PlotDigitizer. https:\/\/Plotdigitizer.com\/n.d."},{"issue":"7454","key":"10.1016\/j.clnu.2025.02.016_bib28","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","year":"2004","journal-title":"Br Med J"},{"key":"10.1016\/j.clnu.2025.02.016_bib29","first-page":"5043","article-title":"Comparative effectiveness of adding omega-3 or vitamin D to standard therapy in preventing and treating episodes of painful crisis in pediatric sickle cell patients","volume":"26","author":"Abdelhalim","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.clnu.2025.02.016_bib30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1089\/acm.2012.0567","article-title":"Influence of lime juice on the severity of sickle cell anemia","volume":"19","author":"Adegoke","year":"2013","journal-title":"J\u00a0Alternative Compl Med"},{"key":"10.1016\/j.clnu.2025.02.016_bib31","first-page":"114","article-title":"Comparative effectiveness of a six-week treatment course of vitamin D 2 and D 3 in children with sickle cell anemia in steady state with hypovitaminosis D: a randomized clinical trial","volume":"10","author":"Adekunle","year":"2021","journal-title":"J\u00a0Hematol"},{"key":"10.1016\/j.clnu.2025.02.016_bib32","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood-2015-05-647107","article-title":"A\u00a0multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children","volume":"126","author":"Brousseau","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clnu.2025.02.016_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MPH.0000000000001673","article-title":"Effect of high-dose vitamin A supplementation in children with sickle cell disease: a randomized, double-blind, dose-finding pilot study","volume":"42","author":"Brownell","year":"2019","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.clnu.2025.02.016_bib34","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S2352-3026(18)30020-6","article-title":"Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial","volume":"5","author":"Cox","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.clnu.2025.02.016_bib35","first-page":"37","article-title":"Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial","volume":"97","author":"Daak","year":"2013","journal-title":"AJCN (Am J Clin Nutr)"},{"key":"10.1016\/j.clnu.2025.02.016_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcmd.2015.03.014","article-title":"Omega 3 (n-3) fatty acids down-regulate nuclear factor-kappa B (NF-\u03baB) gene and blood cell adhesion molecule expression in patients with homozygous sickle cell disease","volume":"55","author":"Daak","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.clnu.2025.02.016_bib37","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/bloodadvances.2018021444","article-title":"Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)","volume":"2","author":"Daak","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.clnu.2025.02.016_bib38","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1097\/MPH.0000000000000355","article-title":"Safety and efficacy of high-dose daily vitamin D3 supplementation in children and young adults with sickle cell disease","volume":"37","author":"Dougherty","year":"2015","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.clnu.2025.02.016_bib39","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.pedhc.2020.04.007","article-title":"Vitamin D supplementation improves health-related quality of life and physical performance in children with sickle cell disease and in healthy children","volume":"34","author":"Dougherty","year":"2020","journal-title":"J\u00a0Pediatr Health Care"},{"key":"10.1016\/j.clnu.2025.02.016_bib40","first-page":"932","article-title":"No improvement in suboptimal vitamin A status with a randomized, double-blind, placebo-controlled trial of vitamin A supplementation in children with sickle cell disease","volume":"96","author":"Dougherty","year":"2012","journal-title":"AJCN (Am J Clin Nutr)"},{"key":"10.1016\/j.clnu.2025.02.016_bib41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0115426502017006365","article-title":"Plasma zinc is an insensitive predictor of zinc status: use of plasma zinc in children with sickle cell disease","volume":"17","author":"Fung","year":"2002","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2025.02.016_bib42","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-2065","article-title":"Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease","volume":"132","author":"Goldman","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnu.2025.02.016_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/bjh.17119","article-title":"Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial","volume":"192","author":"Gr\u00e9goire-Pelchat","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clnu.2025.02.016_bib44","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1182\/bloodadvances.2017013979","article-title":"Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease","volume":"2","author":"Lee","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.clnu.2025.02.016_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.niox.2017.12.009","article-title":"A\u00a0pilot study of a non-invasive oral nitrate stable isotopic method suggests that arginine and citrulline supplementation increases whole-body NO production in Tanzanian children with sickle cell disease","volume":"74","author":"Marealle","year":"2018","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.clnu.2025.02.016_bib46","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3324\/haematol.2013.086637","article-title":"A\u00a0randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes","volume":"98","author":"Morris","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.clnu.2025.02.016_bib47","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1182\/bloodadvances.2022008539","article-title":"Zinc for infection prevention in children with sickle cell anemia: a randomized double-blind placebo-controlled trial","volume":"7","author":"Namazzi","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.clnu.2025.02.016_bib48","first-page":"136","article-title":"Impact of oral L-arginine supplementation on blood pressure dynamics in children with severe sickle cell vaso-occlusive crisis","volume":"11","author":"Onalo","year":"2021","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.clnu.2025.02.016_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1164\/rccm.202108-1930OC","article-title":"Arginine therapy and cardiopulmonary hemodynamics in hospitalized children with sickle cell anemia: a prospective, double-blinded, randomized placebo-controlled clinical trial","volume":"206","author":"Onalo","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnu.2025.02.016_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.26028","article-title":"Randomized control trial of oral arginine therapy for children with sickle cell anemia hospitalized for pain in Nigeria","volume":"96","author":"Onalo","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clnu.2025.02.016_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/bjh.12019","article-title":"High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study","volume":"159","author":"Osunkwo","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clnu.2025.02.016_bib52","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1002\/ajh.26396","article-title":"Safety of intravenous arginine therapy in children with sickle cell disease hospitalized for vaso-occlusive pain: a randomized placebo-controlled trial in progress","volume":"97","author":"Reyes","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clnu.2025.02.016_bib53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/ajcn\/75.2.300","article-title":"Effect of zinc supplementation on growth and body composition in children with sickle cell disease","volume":"75","author":"Zemel","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2025.02.016_bib54","article-title":"Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults","volume":"2","author":"Delgado","year":"2018","journal-title":"J\u00a0Am Acad Orthop Surg Glob Res Rev"},{"key":"10.1016\/j.clnu.2025.02.016_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208362","article-title":"Optimisation of children z-score calculation based on new statistical techniques","volume":"13","author":"Martinez-Millana","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2025.02.016_bib56","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1182\/blood-2022-164768","article-title":"Sickling dynamics differ among the different sickle cell disease genotypes","volume":"140","author":"Sekyonda","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.clnu.2025.02.016_bib57","first-page":"4","article-title":"Differences in the clinical and genotypic presentation of sickle cell disease around the world","volume":"15","author":"Saraf","year":"2014","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.clnu.2025.02.016_bib58","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/nu16020258","article-title":"Sickle cell disease update: new treatments and challenging nutritional interventions","volume":"16","author":"Bell","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2025.02.016_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29463","article-title":"Food insecurity, housing instability, and dietary quality among children with sickle cell disease: assessment from a single urban center","volume":"69","author":"Fern\u00e1ndez","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clnu.2025.02.016_bib60","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/bjh.19265","article-title":"Low vitamin B blood levels in sickle cell disease: data from a large cohort study in Tanzania","volume":"204","author":"Kisali","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clnu.2025.02.016_bib61","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pbc.25940","article-title":"Nutrient insufficiencies\/deficiencies in children with sickle cell disease and its association with increased disease severity","volume":"63","author":"Martyres","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clnu.2025.02.016_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12937-016-0159-8","article-title":"Effects of nutritional intake on disease severity in children with sickle cell disease","volume":"15","author":"Mandese","year":"2015","journal-title":"Nutr J"},{"key":"10.1016\/j.clnu.2025.02.016_bib63","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.21473","article-title":"Opioid use in patients with sickle cell disease during a vaso-occlusive crisis: a systematic review","author":"Arzoun","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.clnu.2025.02.016_bib64","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1111\/jcmm.17402","article-title":"Microbial gut evaluation in an angolan paediatric population with sickle cell disease","volume":"26","author":"Delgadinho","year":"2022","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.clnu.2025.02.016_bib65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00277-023-05589-5","article-title":"Differential expression of adhesion molecules in sickle cell anemia and gut microbiome effect","volume":"103","author":"Delgadinho","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clnu.2025.02.016_bib66","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41588-021-00991-z","article-title":"Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort","volume":"54","author":"Qin","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.clnu.2025.02.016_bib67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12967-019-1938-8","article-title":"Intestinal injury and gut permeability in sickle cell disease","volume":"17","author":"Dutta","year":"2019","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.clnu.2025.02.016_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30397","article-title":"The relationship between nutrition, gut dysbiosis, and pediatric sickle cell pain outcomes: a pilot study","volume":"70","author":"Dike","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clnu.2025.02.016_bib69","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2141.1983.tb02138.x","article-title":"A\u00a0trial of folate supplementation in children with homozygous sickle cell disease","volume":"54","author":"Rabb","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clnu.2025.02.016_bib70","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00043426-198507030-00005","article-title":"Treatment of sickle cell disease in early childhood in Jamaica","volume":"7","author":"Serjeant","year":"1985","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clnu.2025.02.016_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1526-4637.2006.00252.x","article-title":"Pain experience of children with sickle cell disease who had prolonged hospitalizations for acute painful episodes","volume":"9","author":"Jacob","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.clnu.2025.02.016_bib72","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1542\/peds.2014-3470","article-title":"Improving the management of vaso-occlusive episodes in the pediatric emergency department","volume":"136","author":"Kavanagh","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnu.2025.02.016_bib73","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V95.4.1130.003k03a_1130_1136","article-title":"Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises","volume":"95","author":"Benjamin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clnu.2025.02.016_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100982","article-title":"Health related quality of life in children with sickle cell disease: a systematic review and meta-analysis","volume":"56","author":"Stokoe","year":"2022","journal-title":"Blood Rev"},{"key":"10.1016\/j.clnu.2025.02.016_bib75","article-title":"DHA and EPA in sickle cell disease favor clinical improvement and contribute to better quality of life: a qualitative systematic review","volume":"16","author":"Da Conceicao Souza","year":"2024","journal-title":"Curr Drug Res Rev"},{"key":"10.1016\/j.clnu.2025.02.016_bib76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1024\/0300-9831.78.3.139","article-title":"Patients with sickle cell disease have reduced blood antioxidant protection","volume":"78","author":"Ren","year":"2008","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.clnu.2025.02.016_bib77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.plefa.2019.05.004","article-title":"Relationship of omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemia","volume":"146","author":"Setty","year":"2019","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.clnu.2025.02.016_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102482","article-title":"Biochemical and therapeutic effects of omega-3 fatty acids in sickle cell disease","volume":"52","author":"Daak","year":"2020","journal-title":"Compl Ther Med"},{"key":"10.1016\/j.clnu.2025.02.016_bib79","first-page":"7506","article-title":"Cost-effectiveness analysis of adding omega-3 or vitamin D supplementation to standard therapy in treating painful crises of pediatric sickle cell disease patients","volume":"26","author":"Abdelhalima","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.clnu.2025.02.016_bib80","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1186\/s12913-023-09984-6","article-title":"Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study","volume":"23","author":"Marfo","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.clnu.2025.02.016_bib81","series-title":"Sickle Cell Disease Patients in U.S. Hospitals, 2004: Statistical Brief #21","author":"Steiner","year":"2006"},{"key":"10.1016\/j.clnu.2025.02.016_bib82","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00431-020-03656-x","article-title":"Acute care utilization in pediatric sickle cell disease and sickle cell trait in the USA: prevalence, temporal trends, and cost","volume":"179","author":"Peterson","year":"2020","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clnu.2025.02.016_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1215605","article-title":"Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon G\u00e9n\u00e9raliste des B\u00e9n\u00e9ficiaires","volume":"11","author":"Beillat","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.clnu.2025.02.016_bib84","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clnu.2015.07.012","article-title":"A\u00a0systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in community and care home settings","volume":"35","author":"Elia","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2025.02.016_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246700","article-title":"Evidence-based interventions implemented in low-and middle-income countries for sickle cell disease management: a systematic review of randomized controlled trials","volume":"16","author":"Gyamfi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2025.02.016_bib86","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0348","article-title":"Time to invest in sickle cell anemia as a global health priority","volume":"137","author":"McGann","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnu.2025.02.016_bib87","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k1182","article-title":"Funding innovation in neglected diseases","author":"Yamey","year":"2018","journal-title":"Br Med J"},{"key":"10.1016\/j.clnu.2025.02.016_bib88","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/phar.2329","article-title":"Systematic review of l-glutamine for prevention of vaso-occlusive pain crisis in patients with sickle cell disease","volume":"39","author":"Cieri-Hutcherson","year":"2019","journal-title":"Pharmacotherapy"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561425000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561425000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:56:29Z","timestamp":1762275389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561425000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":88,"alternative-id":["S0261561425000512"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2025.02.016","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of nutritional supplementation for children and adolescents with sickle cell disease: A systematic review and meta-analyses","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2025.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}